About Lyndra
Lyndra is a company based in Cambridge (United States) founded in 2015. It operates as a B2B. Lyndra has raised $305.01 million across 15 funding rounds from investors including Gilead, Fujifilm and Sun Pharma. The company has 107 employees as of December 31, 2022. Lyndra offers products and services including LYNX Platform. Lyndra operates in a competitive market with competitors including Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others.
- Headquarter Cambridge, United States
- Employees 107 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lyndra, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$305.01 M (USD)
in 15 rounds
-
Latest Funding Round
$122.75 M (USD), Series C
Dec 15, 2023
-
Investors
Gilead
& 22 more
-
Employee Count
107
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lyndra
Lyndra offers a comprehensive portfolio of products and services, including LYNX Platform.
Enables long-acting oral therapies for various health conditions.
People of Lyndra
Unlock access to complete
Unlock access to complete
Funding Insights of Lyndra
Lyndra has successfully raised a total of $305.01M across 15 strategic funding rounds. The most recent funding activity was a Series C round of $122.75 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lyndra
Lyndra has secured backing from 23 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Gilead, Fujifilm and Sun Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused venture capital firm
|
Locked | Locked | Locked | |
|
Tech & Life Sciences focused early stage VC firm investing in North America
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Lyndra
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lyndra
Investment portfolio details for Lyndra
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lyndra
Detailed financials for Lyndra
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lyndra Comparisons
Peer comparison for Lyndra
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lyndra
Lyndra operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Drugs for CNS disorders are developed and advanced.
|
|
| Locked | Locked | Locked |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| Locked | Locked | Locked |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| Locked | Locked | Locked |
Therapies for neurological and neuropsychiatric diseases are developed.
|
Detailed competitors of Lyndra
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lyndra
Complete news archive for Lyndra
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lyndra
Lyndra was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Lyndra is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Lyndra is a funded company, having raised a total of $305.01M across 15 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Lyndra is 107.
Lyndra Therapeutics focuses on creating the LYNX drug delivery platform, which enables weekly or monthly dosing of medications to reduce the burden of daily pills. The company conducts research in areas like CNS disorders and collaborates with partners for clinical advancements. Based in Massachusetts, USA, it aims to transform patient experiences through innovative oral therapies, including for schizophrenia and malaria, by licensing technology and advancing clinical trials.
Lyndra's top competitors include Jazz Pharmaceuticals, Biohaven Pharmaceutical and Sana Biotechnology.
Lyndra offers LYNX Platform.
Lyndra has 23 investors. Key investors include Gilead, Fujifilm, Sun Pharma, NIH, and AIG.